These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Successful treatment of bullous pemphigoid with omalizumab. London VA; Kim GH; Fairley JA; Woodley DT Arch Dermatol; 2012 Nov; 148(11):1241-3. PubMed ID: 23165827 [No Abstract] [Full Text] [Related]
5. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. Fairley JA; Baum CL; Brandt DS; Messingham KA J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970 [No Abstract] [Full Text] [Related]
6. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200. Yalcin AD; Genc GE; Celik B; Gumuslu S Clin Lab; 2014; 60(3):523-4. PubMed ID: 24697134 [TBL] [Abstract][Full Text] [Related]
7. [Dermatological implications of omalizumab, an anti-IgE antibody]. Di Lucca-Chrisment J Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140 [TBL] [Abstract][Full Text] [Related]
8. Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. Sabroe RA Br J Dermatol; 2014 Jul; 171(1):13-5. PubMed ID: 25066289 [No Abstract] [Full Text] [Related]
9. [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB]. Neumark M; Tal Y; Zlotogorski A; Molho-Pessach V Harefuah; 2020 Jan; 159(1):29-30. PubMed ID: 31930804 [TBL] [Abstract][Full Text] [Related]
10. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema. Azofra J; Díaz C; Antépara I; Jaúregui I; Soriano A; Ferrer M Ann Allergy Asthma Immunol; 2015 May; 114(5):418-9.e1. PubMed ID: 25747788 [No Abstract] [Full Text] [Related]
11. Can omalizumab be effective in chronic eosinophilic pneumonia? Domingo C; Pomares X Chest; 2013 Jan; 143(1):274. PubMed ID: 23276861 [No Abstract] [Full Text] [Related]
12. A case of allergic bronchopulmonary aspergillosis treated with omalizumab. Sastre I; Blanco J; Mata H; García F J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243 [No Abstract] [Full Text] [Related]
13. Biologics and the treatment of chronic rhinosinusitis. Kern RC J Allergy Clin Immunol; 2013 Jan; 131(1):117-8. PubMed ID: 23265697 [No Abstract] [Full Text] [Related]
14. Omalizumab for chronic urticaria. Altman MC; Naimi DR N Engl J Med; 2013 Jun; 368(26):2528-30. PubMed ID: 23802532 [No Abstract] [Full Text] [Related]
15. Omalizumab for chronic urticaria. Benelli E; Ventura A N Engl J Med; 2013 Jun; 368(26):2528. PubMed ID: 23802531 [No Abstract] [Full Text] [Related]
16. Omalizumab for chronic urticaria. Wu K; Long H N Engl J Med; 2013 Jun; 368(26):2527-8. PubMed ID: 23802530 [No Abstract] [Full Text] [Related]
17. Omalizumab for chronic urticaria. Maurer M; Rosén K; Hsieh HJ N Engl J Med; 2013 Jun; 368(26):2530. PubMed ID: 23802529 [No Abstract] [Full Text] [Related]
18. Anti-IgE therapy and severe atopic dermatitis: a pediatric perspective. Lacombe Barrios J; Bégin P; Paradis L; Hatami A; Paradis J; Des Roches A J Am Acad Dermatol; 2013 Nov; 69(5):832-834. PubMed ID: 24124824 [No Abstract] [Full Text] [Related]
19. Should clinicians use omalizumab for the treatment of nasal polyps? Naclerio RM; Baroody FM; Pinto JM J Allergy Clin Immunol; 2013 Jul; 132(1):247. PubMed ID: 23684073 [No Abstract] [Full Text] [Related]